Paper36830003
Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor.
Dilly S and 5 others. Antioxidants (Basel), 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor. Papers, record 36830003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36830003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PCVI-08-006 | Agence Nationale de la Recherche | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20371344 | Macrophage diversity enhances tumor progression and metastasis. | Cell | 2010 | https://conductscience.org/library/papers/20371344 | PubMed |
| 2 | 27756874 | Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue. | Oncotarget | 2016 | https://conductscience.org/library/papers/27756874 | PubMed |
| 3 | 22802674 | Rational design of a fluorescent NADPH derivative imaging constitutive nitric-oxide synthases upon two-photon excitation. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22802674 | PubMed |
| 4 | 28106295 | Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer. | J Cell Biochem | 2017 | https://conductscience.org/library/papers/28106295 | PubMed |
| 5 | 25296975 | Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue. | Oncotarget | 2014 | https://conductscience.org/library/papers/25296975 | PubMed |
| 6 | 31658599 | Redox-Mediated Mechanism of Chemoresistance in Cancer Cells. | Antioxidants (Basel) | 2019 | https://conductscience.org/library/papers/31658599 | PubMed |
| 7 | 36248978 | The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: Enhanced tumor inflammation and metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36248978 | PubMed |
| 8 | 20029835 | Selective probing of a NADPH site controlled light-induced enzymatic catalysis. | J Mol Recognit | 2010 | https://conductscience.org/library/papers/20029835 | PubMed |
| 9 | 17263536 | Synchronous photoinitiation of endothelial NO synthase activity by a nanotrigger targeted at its NADPH site. | J Am Chem Soc | 2007 | https://conductscience.org/library/papers/17263536 | PubMed |
| 10 | 32664318 | Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32664318 | PubMed |
| 11 | 28607049 | Crystal structures and atomic model of NADPH oxidase. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28607049 | PubMed |
| 12 | 20140449 | Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. | Pflugers Arch | 2010 | https://conductscience.org/library/papers/20140449 | PubMed |
| 13 | 27489105 | NADPH Oxidases Are Essential for Macrophage Differentiation. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27489105 | PubMed |
| 14 | 34064498 | Distinction between 2'- and 3'-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34064498 | PubMed |
| 15 | 18719091 | Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. | Endocr Relat Cancer | 2008 | https://conductscience.org/library/papers/18719091 | PubMed |
| 16 | 35584568 | Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation. | Redox Biol | 2022 | https://conductscience.org/library/papers/35584568 | PubMed |
| 17 | 24101477 | Modulation of macrophage phenotype by cell shape. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24101477 | PubMed |
| 18 | 19222033 | NO formation by neuronal NO-synthase can be controlled by ultrafast electron injection from a nanotrigger. | Chembiochem | 2009 | https://conductscience.org/library/papers/19222033 | PubMed |
| 19 | 16116070 | Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. | Circulation | 2005 | https://conductscience.org/library/papers/16116070 | PubMed |
| 20 | 28709950 | Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. | Biochem Pharmacol | 2017 | https://conductscience.org/library/papers/28709950 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42435170 | Metabolic Symbiosis Between Cancer Cells and Endothelial Cells: A Key Driver of Tumor Angiogenesis. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435170 | PubMed |
| 41830967 | CLL-1: An emerging target for immunotherapy in acute myeloid leukemia. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41830967 | PubMed |
| 41403016 | Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies. | Cancer Control | 2025 | https://conductscience.org/library/papers/41403016 | PubMed |
| 41328341 | The application of nanotechnology in regulating mitochondrial function in tumor microenvironment for cancer therapy. | Theranostics | 2026 | https://conductscience.org/library/papers/41328341 | PubMed |
| 40535125 | Research progress on the cross-regulation between ferroptosis and immunogenic cell death in tumor micro-environment. | Front Oncol | 2025 | https://conductscience.org/library/papers/40535125 | PubMed |
| 40266050 | NOX Family: Regulators of Reactive Oxygen Species Balance in Tumor Cells. | FASEB J | 2025 | https://conductscience.org/library/papers/40266050 | PubMed |
| 39940788 | The Role of mtDNA Mutations in Atherosclerosis: The Influence of Mitochondrial Dysfunction on Macrophage Polarization. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39940788 | PubMed |
| 39925677 | Mitochondria-Targeted Biomaterials-Regulating Macrophage Polarization Opens New Perspectives for Disease Treatment. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39925677 | PubMed |
| 39334847 | Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives. | Biomolecules | 2024 | https://conductscience.org/library/papers/39334847 | PubMed |
| 38398634 | Design, Synthesis of Hydrogen Peroxide Response AIE Fluorescence Probes Based on Imidazo [1,2-a] Pyridine. | Molecules | 2024 | https://conductscience.org/library/papers/38398634 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36830003
GET https://conductscience.org/api/papers/v1/36830003/references?page=2